Literature DB >> 31630073

Hemorrhagic complications during extracorporeal membrane oxygenation - The role of anticoagulation and platelets.

Annemieke Oude Lansink-Hartgring1, Adrianus J de Vries2, Joep M Droogh3, Walter M van den Bergh3.   

Abstract

PURPOSE: Hemorrhagic complications during extracorporeal membrane oxygenation are frequent and have a negative impact on outcome. We studied the association between activated partial thromboplastin time or platelet count and the occurrence of hemorrhagic complications. The secondary objective was to determine risk factors for hemorrhagic complications.
METHODS: Retrospective cohort study in a single-center Dutch university hospital. We included all adult patients on extracorporeal membrane oxygenation admitted to the intensive care unit between 2010 and 2017.
RESULTS: We included 164 consecutive patients of which 73 (45%) had a hemorrhagic complication. The most prevalent hemorrhagic complications were surgical site (62%) and cannula site bleeding (18%). Survival to discharge was 67% in the patients without a hemorrhagic complication and 33% in the patients with hemorrhagic complications (p < .01). A higher activated partial thromboplastin time in the 24 h prior was associated with the occurrence of hemorrhagic complications (adjusted hazard ratio per 10 s increase 1.14; (95% CI 1.05-1.24). Venoarterial extracorporeal membrane oxygenation, duration of support, and higher activated partial thromboplastin time were risk factors for the occurrence of hemorrhagic complications.
CONCLUSIONS: Higher activated partial thromboplastin time is associated with the occurrence of hemorrhagic complications.
Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anticoagulation; Bleeding; Extracorporeal membrane oxygenation; Hemorrhage

Year:  2019        PMID: 31630073     DOI: 10.1016/j.jcrc.2019.09.013

Source DB:  PubMed          Journal:  J Crit Care        ISSN: 0883-9441            Impact factor:   3.425


  14 in total

Review 1.  COVID-19 and Extracorporeal Membrane Oxygenation.

Authors:  Gennaro Martucci; Artur Słomka; Steven Eric Lebowitz; Giuseppe Maria Raffa; Pietro Giorgio Malvindi; Valeria Lo Coco; Justyna Swol; Ewa Żekanowska; Roberto Lorusso; Waldemar Wierzba; Piotr Suwalski; Mariusz Kowalewski
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Risk factors for complete recovery of adults after weaning from veno-venous extracorporeal membrane oxygenation for severe acute respiratory failure: an analysis from adult patients in the Extracorporeal Life Support Organization registry.

Authors:  Hye Ju Yeo; Yun Seong Kim; Dohyung Kim; Woo Hyun Cho
Journal:  J Intensive Care       Date:  2020-08-20

Review 3.  COVID-19 and ECMO: the interplay between coagulation and inflammation-a narrative review.

Authors:  Mariusz Kowalewski; Dario Fina; Artur Słomka; Giuseppe Maria Raffa; Gennaro Martucci; Valeria Lo Coco; Maria Elena De Piero; Marco Ranucci; Piotr Suwalski; Roberto Lorusso
Journal:  Crit Care       Date:  2020-05-08       Impact factor: 9.097

4.  Clinical and pathophysiologic aspects of ECMO-associated hemorrhagic complications.

Authors:  Konstantin A Popugaev; Sergey A Bakharev; Kirill V Kiselev; Alexander S Samoylov; Nikolay M Kruglykov; Sergey A Abudeev; Sergey V Zhuravel; Aslan K Shabanov; Thomas Mueller; Stephan A Mayer; Sergey S Petrikov
Journal:  PLoS One       Date:  2020-10-13       Impact factor: 3.240

Review 5.  Device-Induced Hemostatic Disorders in Mechanically Assisted Circulation.

Authors:  Shigang Wang; Bartley P Griffith; Zhongjun J Wu
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

6.  Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.

Authors:  Bruce Cartwright; Hannah M Bruce; Geoffrey Kershaw; Nancy Cai; Jad Othman; David Gattas; Jacqueline L Robson; Sarah Hayes; Hayden Alicajic; Anna Hines; Alice Whyte; Nophanan Chaikittisilpa; Timothy James Southwood; Paul Forrest; Richard J Totaro; Paul G Bannon; Scott Dunkley; Vivien M Chen; Mark Dennis
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

7.  Clinical Features and Risk Factors Analysis for Hemorrhage in Adults on ECMO.

Authors:  Wenwen Hu; Jing Zhang; Meifang Wang; Wei Chen; Lin Chai; Elaine Lai-Han Leung; Yijun Tang
Journal:  Front Med (Lausanne)       Date:  2021-12-14

8.  Major Bleeding in Adults Undergoing Peripheral Extracorporeal Membrane Oxygenation (ECMO): Prognosis and Predictors.

Authors:  Tung Phi Nguyen; Xuan Thi Phan; Tuan Huu Nguyen; Dai Quang Huynh; Linh Thanh Tran; Huy Minh Pham; Tu Ngoc Nguyen; Hieu Trung Kieu; Thao Thi Ngoc Pham
Journal:  Crit Care Res Pract       Date:  2022-01-15

9.  Severe Pulmonary Bleeding after Assist Device Implantation: Incidence, Risk Factors and Prognostic Impact.

Authors:  Bernd Panholzer; Kevin Pilarczyk; Katharina Huenges; Charlotte Aldinger; Christine Friedrich; Ulrike Nowak-Göttl; Jochen Cremer; Assad Haneya
Journal:  J Clin Med       Date:  2022-03-29       Impact factor: 4.241

10.  Proton pump inhibitors versus histamine-2 receptor antagonists for stress ulcer prophylaxis during extracorporeal membrane oxygenation: a propensity score-matched analysis.

Authors:  Yutaka Kondo; Hiroyuki Ohbe; Hiroki Matsui; Kiyohide Fushimi; Hiroshi Tanaka; Hideo Yasunaga
Journal:  BMJ Open       Date:  2020-09-29       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.